Petros Pharmaceuticals annual free cash flow
2020
2024
Petros Pharmaceuticals Free Cash Flow (FCF) History (PTPI)
Petros Pharmaceuticals reported −$2.6M in free cash flow for fiscal 2024, a free cash flow margin of −51.40%.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$2.6M | — | — | −51.40% |
| 2020 | 2020-12-31 | −$15.3M | — | — | −160.15% |
Petros Pharmaceuticals quarterly free cash flow
Q1.20
Q2.20
Q3.20
Q4.20
Q4.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $959,956 | — | — | +132.33% |
| Q4 2020 | 2020-12-31 | −$4.5M | — | — | −154.40% |
| Q3 2020 | 2020-09-30 | −$2.7M | — | — | −76.99% |
| Q2 2020 | 2020-06-30 | −$5.7M | — | — | −417.89% |
| Q1 2020 | 2020-03-31 | −$2.4M | — | — | −132.80% |
Petros Pharmaceuticals free cash flow growth trends
Petros Pharmaceuticals's latest reported quarter, Q4 2024, generated $959,956 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Petros Pharmaceuticals source filings ↗